Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Research Evaluating the Safety and Efficacy of CD70-targeted CAR-NKT Cells (CGC738) Therapy in Subjects With Advanced Clear Cell Renal Cell Carcinoma

NCT06870279 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT06870279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06870279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Research Evaluating the Safety and Efficacy of CD70-targeted CAR-NKT Cells (CGC738) Therapy in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Lead sponsor
RenJi Hospital
Phase
Phase 1
Overall status
Not yet recruiting
Start date
May 25, 2025
Completion date
December 31, 2026
Enrollment
28 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced clear cell renal cell carcinoma